Rare Endocrine Disorder Products | Scientific Exchange

Home > Novo Nordisk Inc. (NNI) Products > Rare Endocrine Disorder Products

Novo Nordisk Inc. (NNI) Products

Novo Nordisk has multiple products on the market for the treatment of Diabetes, Obesity, Growth Hormone Disorders, Hemophilia and Rare Bleeding Disorders. Access information and resources on each of our products below.

Rare Endocrine Disorders

Macrilen^®

60 mg (macimorelin) for oral solution

Macrilen^™ (macimorelin) is a growth hormone secretagogue receptor agonist indicated for the diagnosis of adult growth hormone deficiency.

Safety Data Sheet | Storage & Stability

Prescribing Information

Norditropin^®

(somatropin) injection 5 mg, 10 mg, 15 mg, 30 mg pens

Norditropin^® (somatropin) injection is a recombinant human growth indicated for treatment of pediatric patients with growth failure due to inadequate secretion of endogenous growth hormone (GH), short stature associated with Noonan Syndrome, short stature associated with Turner syndrome, short stature born small for gestational age (SGA) with no catch-up growth by age 2 to 4 years, Idiopathic Short Stature (ISS), and growth failure due to Prader-Willi Syndrome and replacement of endogenous GH in adults with growth hormone deficiency.

Safety Data Sheet | Storage & Stability

Prescribing Information

Sogroya^®

(somapacatin-beco) injection 5 mg/1.5 mL (3.3mg/mL)

Sogroya^® (somapacitan-beco) injection is a human growth hormone analog indicated for replacement of endogenous growth hormone in adults with growth hormone deficiency.

Safety Data Sheet | Storage & Stability

Prescribing Information

Vagifem^®

estradiol vaginal inserts

Vagifem^® (estradiol vaginal inserts) is an estrogen indicated for the treatment of atrophic vaginitis due to menopause.

Safety Data Sheet | Storage & Stability

Prescribing Information

rare
endocrine
disorders

Explore

Additional Information

Speak to a live medical representative.

If you are a healthcare provider from the United States, click below to request information directly from the Novo Nordisk Medical Information department. If you are a patient, please visit https://www.novonordisk-us.com/contact-us.html or call 1-800-727-6500

Start Conversation

Search the Medical Information Database

The Scientific Exchange is a resource for U.S. Healthcare Professionals to learn more about disease states investigated by Novo Nordisk and our related products.

Begin Search

Scientific Exchange is a trademark of Novo Nordisk Health Care AG.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
Non-US Health Care Professionals, please go to www.novonordiskpro.com.